Proposals for changes to EU pharma legislation raise concerns for SMEs
Drug Discovery World
MAY 1, 2023
The Commission states that, currently, there are significant gaps in addressing unmet medical needs, rare diseases and antimicrobial resistance (AMR). The EC also says that earlier availability of generic and biosimilar medicines will be facilitated, and market authorisation procedures simplified.
Let's personalize your content